Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Sunder Mudaliar

Photo of Sunder Mudaliar
Title(s)Clinical Professor, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    University of Madras, Chennai, IndiaMBBS1978Medicine, Surgery, Ob Gyn
    University of Madras , Chennai, India MD (Internal Medicine1985Internal Medicine
    Royal College of Physicians, UKFRCP1989Internal Medicine
    University of Rochester, New YorkABIM1994Internal Medicine
    University of California, San DiegoABEM1997Endocrinology/Metabolism

    Collapse Research 
    Collapse research activities and funding
    Alzheimer's Disease and Alzheimer's Disease Related Dementias in Prediabetes and Type 2 Diabetes: The Diabetes Prevention Program Outcomes Study AD/ADRD Project
    NIH U19AG078558Sep 1, 2022 - Aug 31, 2027
    Role: Co-Investigator
    Intracranial arterial compliance, cerebral blood flow, and dementia risk in older adults with type 2 diabetes
    NIH R01AG063782May 1, 2020 - Feb 28, 2025
    Role: Co-Investigator
    Continuation of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness (GRADE) Study
    NIH U01DK098246Sep 25, 2012 - Jul 31, 2023
    Role: Co-Investigator
    Continuation of Epidemiology of Diabetes Interventions and Complications (EDIC) Study Biostatistics Center
    NIH U01DK094176Aug 15, 2012 - Jun 30, 2023
    Role: Co-Investigator

    Collapse ORNG Applications 
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Longitudinal Metabolic Trajectories in Diabetes Prevention Program Participants Reveal Subgroups With Varying Micro- and Macrovascular Complication Risks. Diabetes Care. 2025 Oct 01; 48(10):1704-1712. Kobayashi E, Linden-Santangeli NJ, Chan N, Toomey CB, Mudaliar S, Temprosa M, Edelstein S, Goyal R, Rangamani P, Majithia AR, Diabetes Prevention Program Research Group . PMID: 40857122; PMCID: PMC12451836.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. Impact of Parental or First-Degree Family History of Diabetes on Diabetes Incidence and Progression During Long-term Follow-up in the Diabetes Prevention Program Outcomes Study. Diabetes Care. 2025 Oct 01; 48(10):1695-1703. Dagogo-Jack S, Kazemi EJ, Doherty L, Srikanthan P, Echouffo-Tcheugui JB, Knowler WC, Kahn SE, Mudaliar S, Temprosa M, DPP Research Group . PMID: 40882001; PMCID: PMC12451838.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    3. Weight Gain Was Associated With Worsening Glycemia and Cardiovascular and Kidney Outcomes in Patients With Type 2 Diabetes Independent of Diabetes Medication in the GRADE Randomized Controlled Trial. Diabetes Care. 2025 Jun 01; 48(6):935-944. Wexler DJ, Garvey WT, Ghosh A, Kazemi EJ, Krause-Steinrauf H, Ahmann AJ, Brown-Friday J, Casula S, Cherrington AL, Elasy TA, Fortmann SP, Krakoff JA, Mudaliar S, Tiktin M, Younes N, GRADE Study Research Group . PMID: 40267365; PMCID: PMC12094209.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    4. Cardiovascular Outcomes in GRADE (Glycemia Reduction Approaches in Type 2 Diabetes: A Comparative Effectiveness Study). Circulation. 2024 03 26; 149(13):993-1003. Green JB, Everett BM, Ghosh A, Younes N, Krause-Steinrauf H, Barzilay J, Desouza C, Inzucchi SE, Pokharel Y, Schade D, Scrymgeour A, Tan MH, Utzschneider KM, Mudaliar S, GRADE Study Research Group. PMID: 38344820; PMCID: PMC10978227.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    5. Type 2 Diabetes Moderates the Association Between Amyloid and 1-Year Change in Everyday Functioning in Older Veterans. J Alzheimers Dis. 2024; 97(1):219-228. Alshaheri Durazo A, Weigand AJ, Bangen KJ, Membreno R, Mudaliar S, Thomas KR, Department of Defense Alzheimer’s Disease Neuroimaging Initiative. PMID: 38160359; PMCID: PMC12369980.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Potential Underlying Mechanisms Explaining the Cardiorenal Benefits of Sodium-Glucose Cotransporter 2 Inhibitors. Adv Ther. 2024 01; 41(1):92-112. Verma S, Mudaliar S, Greasley PJ. PMID: 37943443; PMCID: PMC10796581.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    7. Comparative Effects of Glucose-Lowering Medications on Kidney Outcomes in Type 2 Diabetes: The GRADE Randomized Clinical Trial. JAMA Intern Med. 2023 07 01; 183(7):705-714. Wexler DJ, de Boer IH, Ghosh A, Younes N, Bebu I, Inzucchi SE, McGill JB, Mudaliar S, Schade D, Steffes MW, Tamborlane WV, Tan MH, Ismail-Beigi F, GRADE Research Group. PMID: 37213109; PMCID: PMC10203973.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Astaxanthin, a natural antioxidant, lowers cholesterol and markers of cardiovascular risk in individuals with prediabetes and dyslipidaemia. Diabetes Obes Metab. 2023 07; 25(7):1985-1994. Ciaraldi TP, Boeder SC, Mudaliar SR, Giovannetti ER, Henry RR, Pettus JH. PMID: 36999233; PMCID: PMC10740106.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    9. The Evolution of Diabetes Treatment Through the Ages: From Starvation Diets to Insulin, Incretins, SGLT2-Inhibitors and Beyond. J Indian Inst Sci. 2023 Feb 21; 1-11. Mudaliar S. PMID: 36845885; PMCID: PMC9942084.
      View in: PubMed   Mentions: 3  
    10. Increase in hematocrit with SGLT-2 inhibitors - Hemoconcentration from diuresis or increased erythropoiesis after amelioration of hypoxia? Diabetes Metab Syndr. 2023 Feb; 17(2):102702. Ekanayake P, Mudaliar S. PMID: 36657305.
      View in: PubMed   Mentions: 11     Fields:    Translation:Humans
    11. Sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes: Barriers and solutions for improving uptake in routine clinical practice. Diabetes Obes Metab. 2022 07; 24(7):1187-1196. Khunti K, Jabbour S, Cos X, Mudaliar S, Mende C, Bonaca M, Fioretto P. PMID: 35238129; PMCID: PMC9313799.
      View in: PubMed   Mentions: 15     Fields:    Translation:Humans
    12. A novel hypothesis linking low-grade ketonaemia to cardio-renal benefits with sodium-glucose cotransporter-2 inhibitors. Diabetes Obes Metab. 2022 01; 24(1):3-11. Ekanayake P, Mudaliar S. PMID: 34605129.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    13. Changing the diabetes treatment paradigm from glucose control to cardiorenal protection. Indian J Med Res. 2021 05; 154(5):655-657. Ekanayake P, Mudaliar S. PMID: 35532581; PMCID: PMC9210529.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    14. SGLT2 Inhibitor-Induced Low-Grade Ketonemia Ameliorates Retinal Hypoxia in Diabetic Retinopathy-A Novel Hypothesis. J Clin Endocrinol Metab. 2021 04 23; 106(5):1235-1244. Mudaliar S, Hupfeld C, Chao DL. PMID: 33512450.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansAnimals
    15. Sodium-Glucose Cotransporter Type 2 (SGLT-2) Inhibitors and Ketogenesis: the Good and the Bad. Curr Diab Rep. 2020 11 23; 20(12):74. Ekanayake P, Hupfeld C, Mudaliar S. PMID: 33230620.
      View in: PubMed   Mentions: 19     Fields:    Translation:Humans
    16. A Tribute to Robert Roy Henry-The Classic "Academic Triple Threat": Accomplished Researcher, Inspiring Teacher, and Compassionate Clinician. Diabetes Care. 2020 03; 43(3):522-525. Edelman S, Olefsky J, Mudaliar S, Ciaraldi T, Baron A. PMID: 31964787.
      View in: PubMed   Mentions:    Fields:    
    17. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia. 2019 08; 62(8):1319-1328. Nathan DM, Bennett PH, Crandall JP, Edelstein SL, Goldberg RB, Kahn SE, Knowler WC, Mather KJ, Mudaliar S, Orchard TJ, Temprosa M, White NH, Research Group. PMID: 31270584; PMCID: PMC6818092.
      View in: PubMed   Mentions: 39     Fields:    Translation:Humans
    18. Navigating the "MACE" in Cardiovascular Outcomes Trials and decoding the relevance of Atherosclerotic Cardiovascular Disease benefits versus Heart Failure benefits. Diabetes Obes Metab. 2019 08; 21(8):1780-1789. Hupfeld C, Mudaliar S. PMID: 30957945.
      View in: PubMed   Mentions: 22     Fields:    Translation:Humans
    19. Glucose-dependent Insulinotropic Polypeptide (GIP) Resistance and β-cell Dysfunction Contribute to Hyperglycaemia in Acromegaly. Sci Rep. 2019 04 04; 9(1):5646. Shekhawat VS, Bhansali S, Dutta P, Mukherjee KK, Vaiphei K, Kochhar R, Sinha SK, Sachdeva N, Kurpad AV, Bhat K, Mudaliar S, Bhansali A. PMID: 30948746; PMCID: PMC6449401.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    20. Predictive factors associated with three years of response to HbA1c goals with exenatide QW or insulin glargine: Post-hoc analysis of the DURATION-3 study. Diabetes Obes Metab. 2019 04; 21(4):1049-1053. Guerci B, Trautmann ME, Lin T, Hardy E, Mudaliar SRD. PMID: 30520252.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    21. Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. Diabetes Obes Metab. 2019 04; 21(4):812-821. Cusi K, Bril F, Barb D, Polidori D, Sha S, Ghosh A, Farrell K, Sunny NE, Kalavalapalli S, Pettus J, Ciaraldi TP, Mudaliar S, Henry RR. PMID: 30447037.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansCells
    22. Integrating cardioprotective glucose-lowering medications into clinical practice. Cardiovasc Endocrinol Metab. 2018 Mar; 7(1):24-27. Mudaliar S. PMID: 31646275; PMCID: PMC6739882.
      View in: PubMed   Mentions:
    23. Autologous bone marrow-derived mononuclear cells transplantation in type 2 diabetes mellitus: effect on β-cell function and insulin sensitivity. Diabetol Metab Syndr. 2017; 9:50. Bhansali S, Dutta P, Yadav MK, Jain A, Mudaliar S, Hawkins M, Kurpad AV, Pahwa D, Yadav AK, Sharma RR, Jha V, Marwaha N, Bhansali S, Bhansali A. PMID: 28690682; PMCID: PMC5496640.
      View in: PubMed   Mentions: 7  
    24. Dapagliflozin in patients with type 1 diabetes: A post hoc analysis of the effect of insulin dose adjustments on 24-hour continuously monitored mean glucose and fasting β-hydroxybutyrate levels in a phase IIa pilot study. Diabetes Obes Metab. 2017 06; 19(6):814-821. Henry RR, Dandona P, Pettus J, Mudaliar S, Xu J, Hansen L. PMID: 28098426.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCTClinical Trials
    25. Efficacy of Autologous Bone Marrow-Derived Mesenchymal Stem Cell and Mononuclear Cell Transplantation in Type 2 Diabetes Mellitus: A Randomized, Placebo-Controlled Comparative Study. Stem Cells Dev. 2017 04 01; 26(7):471-481. Bhansali S, Dutta P, Kumar V, Yadav MK, Jain A, Mudaliar S, Bhansali S, Sharma RR, Jha V, Marwaha N, Khandelwal N, Srinivasan A, Sachdeva N, Hawkins M, Bhansali A. PMID: 28006991.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansCells
    26. Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetes. Diabetes Obes Metab. 2016 10; 18 Suppl 2:17-24. Mudaliar S, Henry RR, Ciaraldi TP, Armstrong DA, Burke PM, Pettus JH, Garhyan P, Choi SL, Knadler MP, Lam EC, Prince MJ, Bose N, Porksen NK, Sinha VP, Linnebjerg H, Jacober SJ. PMID: 27723226.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    27. Pioglitazone is equally effective for diabetes prevention in older versus younger adults with impaired glucose tolerance. Age (Dordr). 2016 Dec; 38(5-6):485-493. Espinoza SE, Wang CP, Tripathy D, Clement SC, Schwenke DC, Banerji MA, Bray GA, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Stentz FB, Reaven PD, DeFronzo RA, Musi N. PMID: 27585671; PMCID: PMC5266219.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    28. Altered Myokine Secretion Is an Intrinsic Property of Skeletal Muscle in Type 2 Diabetes. PLoS One. 2016; 11(7):e0158209. Ciaraldi TP, Ryan AJ, Mudaliar SR, Henry RR. PMID: 27453994; PMCID: PMC4959771.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansCells
    29. Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis. Diabetes Care. 2016 Jul; 39(7):1115-22. Mudaliar S, Alloju S, Henry RR. PMID: 27289124.
      View in: PubMed   Mentions: 275     Fields:    Translation:Humans
    30. Diabetes Incidence and Glucose Tolerance after Termination of Pioglitazone Therapy: Results from ACT NOW. J Clin Endocrinol Metab. 2016 05; 101(5):2056-62. Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, DeFronzo RA. PMID: 26982008; PMCID: PMC6287507.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    31. The Effects of Aging on Hemoglobin A1c Levels--The Potential Role of the Glycemic Gap. Diabetes Technol Ther. 2016 Apr; 18(4):216-7. Alloju S, Mudaliar S. PMID: 26909876.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    32. AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes. Diabetes Obes Metab. 2016 Feb; 18(2):191-5. Katz L, Manamley N, Snyder WJ, Dodds M, Agafonova N, Sierra-Johnson J, Cruz M, Kaur P, Mudaliar S, Raskin P, Kewalramani R, Pellacani A. PMID: 26434934.
      View in: PubMed   Mentions: 18     Fields:    Translation:HumansCTClinical Trials
    33. Sodium-Glucose Cotransporter Inhibitors: Effects on Renal and Intestinal Glucose Transport: From Bench to Bedside. Diabetes Care. 2015 Dec; 38(12):2344-53. Mudaliar S, Polidori D, Zambrowicz B, Henry RR. PMID: 26604280.
      View in: PubMed   Mentions: 104     Fields:    Translation:HumansAnimals
    34. Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptor. Am J Physiol Endocrinol Metab. 2015 Jul 01; 309(1):E22-34. Amir Levy Y, Ciaraldi TP, Mudaliar SR, Phillips SA, Henry RR. PMID: 25944879.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    35. A novel insulin resistance index to monitor changes in insulin sensitivity and glucose tolerance: the ACT NOW study. J Clin Endocrinol Metab. 2015 May; 100(5):1855-62. Tripathy D, Cobb JE, Gall W, Adam KP, George T, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Reaven PD, Musi N, Ferrannini E, DeFronzo RA. PMID: 25603459; PMCID: PMC4422894.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    36. Exploring the potential of the SGLT2 inhibitor dapagliflozin in type 1 diabetes: a randomized, double-blind, placebo-controlled pilot study. Diabetes Care. 2015 Mar; 38(3):412-9. Henry RR, Rosenstock J, Edelman S, Mudaliar S, Chalamandaris AG, Kasichayanula S, Bogle A, Iqbal N, List J, Griffen SC. PMID: 25271207.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    37. Basal insulin peglispro demonstrates preferential hepatic versus peripheral action relative to insulin glargine in healthy subjects. Diabetes Care. 2014 Sep; 37(9):2609-15. Henry RR, Mudaliar S, Ciaraldi TP, Armstrong DA, Burke P, Pettus J, Garhyan P, Choi SL, Jacober SJ, Knadler MP, Lam EC, Prince MJ, Bose N, Porksen N, Sinha VP, Linnebjerg H. PMID: 24947791.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    38. Baseline adiponectin levels do not influence the response to pioglitazone in ACT NOW. Diabetes Care. 2014 Jun; 37(6):1706-11. Tripathy D, Clement SC, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, DeFronzo RA. PMID: 24705615; PMCID: PMC4179517.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    39. Changes in insulin sensitivity and insulin secretion with the sodium glucose cotransporter 2 inhibitor dapagliflozin. Diabetes Technol Ther. 2014 Mar; 16(3):137-44. Mudaliar S, Henry RR, Boden G, Smith S, Chalamandaris AG, Duchesne D, Iqbal N, List J. PMID: 24237386.
      View in: PubMed   Mentions: 50     Fields:    Translation:HumansCTClinical Trials
    40. Prediction of diabetes based on baseline metabolic characteristics in individuals at high risk. Diabetes Care. 2013 Nov; 36(11):3607-12. Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, Gastaldelli A, ACT NOW Study. PMID: 24062330; PMCID: PMC3816921.
      View in: PubMed   Mentions: 34     Fields:    Translation:HumansCells
    41. Choice of early treatment regimen and impact on β-cell preservation in type 2 diabetes. Int J Clin Pract. 2013 Sep; 67(9):876-87. Mudaliar S. PMID: 23952467.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansCells
    42. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment. Metabolism. 2013 Nov; 62(11):1587-96. Ciaraldi TP, Aroda V, Mudaliar SR, Henry RR. PMID: 23958241.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    43. Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates. Diabetes. 2013 Nov; 62(11):3920-6. Defronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Gastaldelli A, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Reaven PD, ACT NOW Study. PMID: 23863810; PMCID: PMC3806596.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCells
    44. Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers. J Clin Endocrinol Metab. 2013 Aug; 98(8):3446-53. Henry RR, Ciaraldi TP, Armstrong D, Burke P, Ligueros-Saylan M, Mudaliar S. PMID: 23733372.
      View in: PubMed   Mentions: 117     Fields:    Translation:Humans
    45. Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. Gastroenterology. 2013 Sep; 145(3):574-82.e1. Mudaliar S, Henry RR, Sanyal AJ, Morrow L, Marschall HU, Kipnes M, Adorini L, Sciacca CI, Clopton P, Castelloe E, Dillon P, Pruzanski M, Shapiro D. PMID: 23727264.
      View in: PubMed   Mentions: 419     Fields:    Translation:Humans
    46. Effect of pioglitazone on body composition and bone density in subjects with prediabetes in the ACT NOW trial. Diabetes Obes Metab. 2013 Oct; 15(10):931-7. Bray GA, Smith SR, Banerji MA, Tripathy D, Clement SC, Buchanan TA, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner RE, Schwenke DC, Stentz FB, Reaven PD, DeFronzo RA. PMID: 23551856.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansCTClinical Trials
    47. Evolution of exenatide as a diabetes therapeutic. Curr Diabetes Rev. 2013 Mar 01; 9(2):161-93. Bhavsar S, Mudaliar S, Cherrington A. PMID: 23256660; PMCID: PMC3664512.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimals
    48. Canagliflozin lowers postprandial glucose and insulin by delaying intestinal glucose absorption in addition to increasing urinary glucose excretion: results of a randomized, placebo-controlled study. Diabetes Care. 2013 Aug; 36(8):2154-61. Polidori D, Sha S, Mudaliar S, Ciaraldi TP, Ghosh A, Vaccaro N, Farrell K, Rothenberg P, Henry RR. PMID: 23412078; PMCID: PMC3714520.
      View in: PubMed   Mentions: 116     Fields:    Translation:Humans
    49. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization. J Clin Psychiatry. 2013 Jan; 74(1):10-8. Jin H, Shih PA, Golshan S, Mudaliar S, Henry R, Glorioso DK, Arndt S, Kraemer HC, Jeste DV. PMID: 23218100; PMCID: PMC3600635.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    50. Pioglitazone slows progression of atherosclerosis in prediabetes independent of changes in cardiovascular risk factors. Arterioscler Thromb Vasc Biol. 2013 Feb; 33(2):393-9. Saremi A, Schwenke DC, Buchanan TA, Hodis HN, Mack WJ, Banerji M, Bray GA, Clement SC, Henry RR, Kitabchi AE, Mudaliar S, Ratner RE, Stentz FB, Musi N, Tripathy D, DeFronzo RA, Reaven PD. PMID: 23175674; PMCID: PMC3908828.
      View in: PubMed   Mentions: 57     Fields:    Translation:Humans
    51. Remogliflozin etabonate, a selective inhibitor of the sodium-glucose transporter 2, improves serum glucose profiles in type 1 diabetes. Diabetes Care. 2012 Nov; 35(11):2198-200. Mudaliar S, Armstrong DA, Mavian AA, O'Connor-Semmes R, Mydlow PK, Ye J, Hussey EK, Nunez DJ, Henry RR, Dobbins RL. PMID: 23011728; PMCID: PMC3476920.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    52. The incretin hormones: from scientific discovery to practical therapeutics. Diabetologia. 2012 Jul; 55(7):1865-8. Mudaliar S, Henry RR. PMID: 22555471.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    53. Efficacy and safety of taspoglutide in patients with type 2 diabetes inadequately controlled with metformin plus pioglitazone over 24 weeks: T-Emerge 3 trial. J Clin Endocrinol Metab. 2012 Jul; 97(7):2370-9. Henry RR, Mudaliar S, Kanitra L, Woloschak M, Balena R, T-Emerge 3 Study Group. PMID: 22539590.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCTClinical Trials
    54. Effects of colesevelam on glucose absorption and hepatic/peripheral insulin sensitivity in patients with type 2 diabetes mellitus. Diabetes Obes Metab. 2012 Jan; 14(1):40-6. Henry RR, Aroda VR, Mudaliar S, Garvey WT, Chou HS, Jones MR. PMID: 21831167; PMCID: PMC4955577.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    55. Effects of saxagliptin on β-cell stimulation and insulin secretion in patients with type 2 diabetes. Diabetes Obes Metab. 2011 Sep; 13(9):850-8. Henry RR, Smith SR, Schwartz SL, Mudaliar SR, Deacon CF, Holst JJ, Duan RY, Chen RS, List JF. PMID: 21554520.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCells
    56. Impact of olanzapine or risperidone treatment on insulin sensitivity in schizophrenia or schizoaffective disorder. Diabetes Obes Metab. 2011 Aug; 13(8):726-35. Hardy TA, Henry RR, Forrester TD, Kryzhanovskaya LA, Campbell GM, Marks DM, Mudaliar S. PMID: 21435142.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    57. Effects of intensive insulin therapy alone and in combination with pioglitazone on body weight, composition, distribution and liver fat content in patients with type 2 diabetes. Diabetes Obes Metab. 2011 Jun; 13(6):505-10. Shah PK, Mudaliar S, Chang AR, Aroda V, Andre M, Burke P, Henry RR. PMID: 21272186; PMCID: PMC3580155.
      View in: PubMed   Mentions: 23     Fields:    Translation:Humans
    58. Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011 Mar 24; 364(12):1104-15. DeFronzo RA, Tripathy D, Schwenke DC, Banerji M, Bray GA, Buchanan TA, Clement SC, Henry RR, Hodis HN, Kitabchi AE, Mack WJ, Mudaliar S, Ratner RE, Williams K, Stentz FB, Musi N, Reaven PD, ACT NOW Study. PMID: 21428766.
      View in: PubMed   Mentions: 289     Fields:    Translation:Humans
    59. Increased Framingham 10-year risk of coronary heart disease in middle-aged and older patients with psychotic symptoms. Schizophr Res. 2011 Feb; 125(2-3):295-9. Jin H, Folsom D, Sasaki A, Mudaliar S, Henry R, Torres M, Golshan S, Glorioso DK, Jeste D. PMID: 21093219; PMCID: PMC3031775.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    60. Use of clinical markers to identify metabolic syndrome in antipsychotic-treated patients. J Clin Psychiatry. 2010 Oct; 71(10):1273-8. Jin H, Meyer J, Mudaliar S, Henry R, Khandrika S, Glorioso DK, Kraemer H, Jeste D. PMID: 21062616.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    61. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2010 Aug 21; 376(9741):595-605. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, Kim DD, Dunayevich E, COR-I Study Group. PMID: 20673995.
      View in: PubMed   Mentions: 346     Fields:    Translation:HumansCTClinical Trials
    62. Telmisartan effects on insulin resistance in obese or overweight adults without diabetes or hypertension. J Clin Hypertens (Greenwich). 2010 Sep; 12(9):746-52. Hsueh W, Davidai G, Henry R, Mudaliar S. PMID: 20883237; PMCID: PMC8672967.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCTClinical Trials
    63. Pioglitazone: side effect and safety profile. Expert Opin Drug Saf. 2010 Mar; 9(2):347-54. Shah P, Mudaliar S. PMID: 20175701.
      View in: PubMed   Mentions: 86     Fields:    Translation:HumansAnimals
    64. Effects of incretin hormones on beta-cell mass and function, body weight, and hepatic and myocardial function. Am J Med. 2010 Mar; 123(3 Suppl):S19-27. Mudaliar S, Henry RR. PMID: 20206728.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansAnimalsCells
    65. Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study. Diabetologia. 2010 Mar; 53(3):435-45. DeFronzo RA, Banerji MA, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven P, Schwenke DC, Stentz FD, Tripathy D, ACT NOW Study Group. PMID: 20012012.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansCells
    66. Effects of intensive insulin therapy alone and with added pioglitazone on renal salt/water balance and fluid compartment shifts in type 2 diabetes. Diabetes Obes Metab. 2010 Feb; 12(2):133-8. Mudaliar S, Chang AR, Aroda VR, Chao E, Burke P, Baxi S, Griver KA, O'Connor DT, Henry RR. PMID: 19889003.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    67. Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes. Curr Med Res Opin. 2009 Sep; 25(9):2239-49. Jones MR, Mudaliar S, Hernandez-Triana E, Unnikrishnan AG, Lai YL, Abby SL, Misir S, Jin X, Nagendran S. PMID: 19622007.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    68. Serum glucose control in diabetic patients with cardiovascular disease: should we be less aggressive? Curr Atheroscler Rep. 2009 Sep; 11(5):384-90. Mudaliar S. PMID: 19664383.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    69. Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis. Diabetes. 2009 Nov; 58(11):2642-8. Reaven PD, Moritz TE, Schwenke DC, Anderson RJ, Criqui M, Detrano R, Emanuele N, Kayshap M, Marks J, Mudaliar S, Harsha Rao R, Shah JH, Goldman S, Reda DJ, McCarren M, Abraira C, Duckworth W, Veterans Affairs Diabetes Trial. PMID: 19651816; PMCID: PMC2768182.
      View in: PubMed   Mentions: 67     Fields:    Translation:Humans
    70. Discontinuation of quetiapine from an NIMH-funded trial due to serious adverse events. Am J Psychiatry. 2009 Aug; 166(8):937-8. Jeste DV, Jin H, Golshan S, Mudaliar S, Glorioso D, Fellows I, Kraemer H, Arndt S. PMID: 19651757.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    71. Actos Now for the prevention of diabetes (ACT NOW) study. BMC Endocr Disord. 2009 Jul 29; 9:17. Defronzo RA, Banerji M, Bray GA, Buchanan TA, Clement S, Henry RR, Kitabchi AE, Mudaliar S, Musi N, Ratner R, Reaven PD, Schwenke D, Stentz FB, Tripathy D. PMID: 19640291; PMCID: PMC2725044.
      View in: PubMed   Mentions: 29     Fields:    
    72. Selective regulation of cellular and secreted multimeric adiponectin by antidiabetic therapies in humans. Am J Physiol Endocrinol Metab. 2009 Sep; 297(3):E767-73. Phillips SA, Kung J, Ciaraldi TP, Choe C, Christiansen L, Mudaliar S, Henry RR. PMID: 19622782; PMCID: PMC2739702.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    73. Incretin therapies: effects beyond glycemic control. Eur J Intern Med. 2009 Jul; 20 Suppl 2:S319-28. Mudaliar S, Henry RR. PMID: 19580951.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    74. Effect of the dual peroxisome proliferator-activated receptor-alpha/gamma agonist aleglitazar on risk of cardiovascular disease in patients with type 2 diabetes (SYNCHRONY): a phase II, randomised, dose-ranging study. Lancet. 2009 Jul 11; 374(9684):126-35. Henry RR, Lincoff AM, Mudaliar S, Rabbia M, Chognot C, Herz M. PMID: 19515415.
      View in: PubMed   Mentions: 68     Fields:    Translation:HumansCTClinical Trials
    75. GSK-3beta and control of glucose metabolism and insulin action in human skeletal muscle. Mol Cell Endocrinol. 2010 Feb 05; 315(1-2):153-8. Ciaraldi TP, Carter L, Mudaliar S, Henry RR. PMID: 19505532; PMCID: PMC2819161.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    76. Association of posttraumatic stress disorder with increased prevalence of metabolic syndrome. J Clin Psychopharmacol. 2009 Jun; 29(3):210-5. Jin H, Lanouette NM, Mudaliar S, Henry R, Folsom DP, Khandrika S, Glorioso DK, Jeste DV. PMID: 19440072; PMCID: PMC3640506.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    77. Incretin therapies: effects beyond glycemic control. Am J Med. 2009 Jun; 122(6 Suppl):S25-36. Mudaliar S, Henry RR. PMID: 19464425.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCells
    78. Metabolic and hormonal changes induced by pioglitazone in polycystic ovary syndrome: a randomized, placebo-controlled clinical trial. J Clin Endocrinol Metab. 2009 Feb; 94(2):469-76. Aroda VR, Ciaraldi TP, Burke P, Mudaliar S, Clopton P, Phillips S, Chang RJ, Henry RR. PMID: 18984667; PMCID: PMC2646515.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    79. Polycystic ovary syndrome is associated with tissue-specific differences in insulin resistance. J Clin Endocrinol Metab. 2009 Jan; 94(1):157-63. Ciaraldi TP, Aroda V, Mudaliar S, Chang RJ, Henry RR. PMID: 18854391; PMCID: PMC2630871.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCells
    80. Impact of atypical antipsychotic therapy on leptin, ghrelin, and adiponectin. Schizophr Res. 2008 Mar; 100(1-3):70-85. Jin H, Meyer JM, Mudaliar S, Jeste DV. PMID: 18206351; PMCID: PMC2699769.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansAnimals
    81. Inhaled insulin using AERx insulin Diabetes Management System (AERx iDMS). Expert Opin Investig Drugs. 2007 Oct; 16(10):1673-81. Mudaliar S. PMID: 17922630.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    82. Inhaled insulin in patients with asthma and chronic obstructive pulmonary disease. Diabetes Technol Ther. 2007 Jun; 9 Suppl 1:S83-92. Mudaliar S, Henry RR. PMID: 17563308.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    83. New frontiers in the management of type 2 diabetes. Indian J Med Res. 2007 Mar; 125(3):275-96. Mudaliar S. PMID: 17496356.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    84. Significant insulin dose errors may occur if blood glucose results are obtained from miscoded meters. J Diabetes Sci Technol. 2007 Mar; 1(2):205-10. Raine CH, Schrock LE, Edelman SV, Mudaliar SR, Zhong W, Proud LJ, Parkes JL. PMID: 19888408; PMCID: PMC2771463.
      View in: PubMed   Mentions: 20     Fields:    
    85. A lifestyle intervention for older schizophrenia patients with diabetes mellitus: a randomized controlled trial. Schizophr Res. 2006 Sep; 86(1-3):36-44. McKibbin CL, Patterson TL, Norman G, Patrick K, Jin H, Roesch S, Mudaliar S, Barrio C, O'Hanlon K, Griver K, Sirkin A, Jeste DV. PMID: 16842977.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansCTClinical Trials
    86. Tissue-specific expression and regulation of GSK-3 in human skeletal muscle and adipose tissue. Am J Physiol Endocrinol Metab. 2006 Nov; 291(5):E891-8. Ciaraldi TP, Oh DK, Christiansen L, Nikoulina SE, Kong AP, Baxi S, Mudaliar S, Henry RR. PMID: 16757548.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCellsCTClinical Trials
    87. Diabetes treatments have differential effects on nontraditional cardiovascular risk factors. J Diabetes Complications. 2006 Jan-Feb; 20(1):14-20. Fonseca VA, Theuma P, Mudaliar S, Leissinger CA, Clejan S, Henry RR. PMID: 16389162.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    88. Efforts to improve subsequent treatment of cardiovascular risk factors in older patients with diabetes hospitalized for a cardiac event. Am J Manag Care. 2005 Dec; 11(12):758-64. Echeverry D, Dike M, Jovanovic L, Wollitzer AO, Westphal S, Mudaliar S, Washington C, Davidson MB. PMID: 16336059.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    89. Adipocyte differentiation-related protein in human skeletal muscle: relationship to insulin sensitivity. Obes Res. 2005 Aug; 13(8):1321-9. Phillips SA, Choe CC, Ciaraldi TP, Greenberg AS, Kong AP, Baxi SC, Christiansen L, Mudaliar SR, Henry RR. PMID: 16129713.
      View in: PubMed   Mentions: 24     Fields:    Translation:HumansCells
    90. Effects of the rapid-acting insulin analog glulisine on cultured human skeletal muscle cells: comparisons with insulin and insulin-like growth factor I. J Clin Endocrinol Metab. 2005 Oct; 90(10):5551-8. Ciaraldi TP, Phillips SA, Carter L, Aroda V, Mudaliar S, Henry RR. PMID: 16030168.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    91. Assessment of capacity to consent to research among older persons with schizophrenia, Alzheimer disease, or diabetes mellitus: comparison of a 3-item questionnaire with a comprehensive standardized capacity instrument. Arch Gen Psychiatry. 2005 Jul; 62(7):726-33. Palmer BW, Dunn LB, Appelbaum PS, Mudaliar S, Thal L, Henry R, Golshan S, Jeste DV. PMID: 15997013.
      View in: PubMed   Mentions: 85     Fields:    Translation:HumansPHPublic Health
    92. Impaired fatty acid metabolism in type 2 diabetic skeletal muscle cells is reversed by PPARgamma agonists. Am J Physiol Endocrinol Metab. 2005 Jul; 289(1):E151-9. Cha BS, Ciaraldi TP, Park KS, Carter L, Mudaliar SR, Henry RR. PMID: 15727952.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCellsCTClinical Trials
    93. Skeletal muscle GLUT1 transporter protein expression and basal leg glucose uptake are reduced in type 2 diabetes. J Clin Endocrinol Metab. 2005 Jan; 90(1):352-8. Ciaraldi TP, Mudaliar S, Barzin A, Macievic JA, Edelman SV, Park KS, Henry RR. PMID: 15483099.
      View in: PubMed   Mentions: 21     Fields:    Translation:Humans
    94. Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. J Am Coll Cardiol. 2004 Sep 01; 44(5):1047-52. Bhalla MA, Chiang A, Epshteyn VA, Kazanegra R, Bhalla V, Clopton P, Krishnaswamy P, Morrison LK, Chiu A, Gardetto N, Mudaliar S, Edelman SV, Henry RR, Maisel AS. PMID: 15337217.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    95. Intense management of diabetes mellitus: role of glucose control and antiplatelet agents. J Clin Pharmacol. 2004 Apr; 44(4):414-22. Mudaliar S. PMID: 15051750.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    96. Evaluation of insulin sensitivity in healthy volunteers treated with olanzapine, risperidone, or placebo: a prospective, randomized study using the two-step hyperinsulinemic, euglycemic clamp. J Clin Endocrinol Metab. 2003 Dec; 88(12):5875-80. Sowell M, Mukhopadhyay N, Cavazzoni P, Carlson C, Mudaliar S, Chinnapongse S, Ray A, Davis T, Breier A, Henry RR, Dananberg J. PMID: 14671184.
      View in: PubMed   Mentions: 25     Fields:    Translation:HumansCTClinical Trials
    97. Young and elderly type 2 diabetic patients inhaling insulin with the AERx insulin diabetes management system: a pharmacokinetic and pharmacodynamic comparison. J Clin Pharmacol. 2003 Nov; 43(11):1228-34. Henry RR, Mudaliar S, Chu N, Kim D, Armstrong D, Davis TT, An B, Reinhardt RR. PMID: 14551177.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCTClinical Trials
    98. Dose-response relationships of inhaled insulin delivered via the Aerodose insulin inhaler and subcutaneously injected insulin in patients with type 2 diabetes. Diabetes Care. 2003 Oct; 26(10):2842-7. Kim D, Mudaliar S, Chinnapongse S, Chu N, Boies SM, Davis T, Perera AD, Fishman RS, Shapiro DA, Henry R. PMID: 14514589.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCTClinical Trials
    99. Thiazolidinediones, peripheral edema, and type 2 diabetes: incidence, pathophysiology, and clinical implications. Endocr Pract. 2003 Sep-Oct; 9(5):406-16. Mudaliar S, Chang AR, Henry RR. PMID: 14583425.
      View in: PubMed   Mentions: 54     Fields:    Translation:Humans
    100. Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study. Diabetes Care. 2003 Sep; 26(9):2598-603. Raskin P, Bode BW, Marks JB, Hirsch IB, Weinstein RL, McGill JB, Peterson GE, Mudaliar SR, Reinhardt RR. PMID: 12941725.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansCTClinical Trials
    101. Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. Diabetes Care. 2003 Jul; 26(7):2081-7. Epshteyn V, Morrison K, Krishnaswamy P, Kazanegra R, Clopton P, Mudaliar S, Edelman S, Henry R, Maisel A. PMID: 12832317.
      View in: PubMed   Mentions: 28     Fields:    Translation:Humans
    102. Regulation of skeletal muscle morphology in type 2 diabetic subjects by troglitazone and metformin: relationship to glucose disposal. Metabolism. 2003 May; 52(5):540-6. Mathieu-Costello O, Kong A, Ciaraldi TP, Cui L, Ju Y, Chu N, Kim D, Mudaliar S, Henry RR. PMID: 12759881.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCellsCTClinical Trials
    103. A pilot study on CD4 & CD8 cell counts in healthy HIV seronegative pregnant women. Indian J Med Res. 2003 May; 117:198-200. Dayama A, Pandit D, Mudaliar S, Bharadwaj R, Bharucha KE, Shrotri AN, Joshi S. PMID: 14609046.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    104. Thiazolidinediones upregulate impaired fatty acid uptake in skeletal muscle of type 2 diabetic subjects. Am J Physiol Endocrinol Metab. 2003 Aug; 285(2):E354-62. Wilmsen HM, Ciaraldi TP, Carter L, Reehman N, Mudaliar SR, Henry RR. PMID: 12700163.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    105. Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes. 2003 Mar; 52(3):667-74. Phillips SA, Ciaraldi TP, Kong AP, Bandukwala R, Aroda V, Carter L, Baxi S, Mudaliar SR, Henry RR. PMID: 12606507.
      View in: PubMed   Mentions: 49     Fields:    Translation:HumansCellsCTClinical Trials
    106. Inhaled insulin using the AERx Insulin Diabetes Management System in healthy and asthmatic subjects. Diabetes Care. 2003 Mar; 26(3):764-9. Henry RR, Mudaliar SR, Howland WC, Chu N, Kim D, An B, Reinhardt RR. PMID: 12610035.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCTClinical Trials
    107. Impact of pramlintide on glucose fluctuations and postprandial glucose, glucagon, and triglyceride excursions among patients with type 1 diabetes intensively treated with insulin pumps. Diabetes Care. 2003 Jan; 26(1):1-8. Levetan C, Want LL, Weyer C, Strobel SA, Crean J, Wang Y, Maggs DG, Kolterman OG, Chandran M, Mudaliar SR, Henry RR. PMID: 12502651.
      View in: PubMed   Mentions: 37     Fields:    Translation:HumansCTClinical Trials
    108. Intravenous glargine and regular insulin have similar effects on endogenous glucose output and peripheral activation/deactivation kinetic profiles. Diabetes Care. 2002 Sep; 25(9):1597-602. Mudaliar S, Mohideen P, Deutsch R, Ciaraldi TP, Armstrong D, Kim B, Sha X, Henry RR. PMID: 12196433.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    109. Insulin and insulin-like growth factor-1 action on human skeletal muscle: preferential effects of insulin-like growth factor-1 in type 2 diabetic subjects. Metabolism. 2002 Sep; 51(9):1171-9. Ciaraldi TP, Carter L, Rehman N, Mohideen P, Mudaliar S, Henry RR. PMID: 12200763.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    110. Inhibition of glycogen synthase kinase 3 improves insulin action and glucose metabolism in human skeletal muscle. Diabetes. 2002 Jul; 51(7):2190-8. Nikoulina SE, Ciaraldi TP, Mudaliar S, Carter L, Johnson K, Henry RR. PMID: 12086949.
      View in: PubMed   Mentions: 62     Fields:    Translation:HumansCells
    111. Free fatty acid metabolism in human skeletal muscle is regulated by PPARgamma and RXR agonists. Ann N Y Acad Sci. 2002 Jun; 967:66-70. Ciaraldi TP, Cha BS, Park KS, Carter L, Mudaliar SR, Henry RR. PMID: 12079836.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    112. Differential effects of metformin and troglitazone on cardiovascular risk factors in patients with type 2 diabetes. Diabetes Care. 2002 Mar; 25(3):542-9. Chu NV, Kong AP, Kim DD, Armstrong D, Baxi S, Deutsch R, Caulfield M, Mudaliar SR, Reitz R, Henry RR, Reaven PD. PMID: 11874944.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCTClinical Trials
    113. Troglitazone but not metformin restores insulin-stimulated phosphoinositide 3-kinase activity and increases p110beta protein levels in skeletal muscle of type 2 diabetic subjects. Diabetes. 2002 Feb; 51(2):443-8. Kim YB, Ciaraldi TP, Kong A, Kim D, Chu N, Mohideen P, Mudaliar S, Henry RR, Kahn BB. PMID: 11812753.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansCTClinical Trials
    114. Regulation of glucose transport and insulin signaling by troglitazone or metformin in adipose tissue of type 2 diabetic subjects. Diabetes. 2002 Jan; 51(1):30-6. Ciaraldi TP, Kong AP, Chu NV, Kim DD, Baxi S, Loviscach M, Plodkowski R, Reitz R, Caulfield M, Mudaliar S, Henry RR. PMID: 11756319.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansCellsCTClinical Trials
    115. Insulin therapy in type 2 diabetes. Endocrinol Metab Clin North Am. 2001 Dec; 30(4):935-82. Mudaliar S, Edelman SV. PMID: 11727406.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    116. Effects of the long-acting insulin analog insulin glargine on cultured human skeletal muscle cells: comparisons to insulin and IGF-I. J Clin Endocrinol Metab. 2001 Dec; 86(12):5838-47. Ciaraldi TP, Carter L, Seipke G, Mudaliar S, Henry RR. PMID: 11739448.
      View in: PubMed   Mentions: 21     Fields:    Translation:HumansCells
    117. Impaired muscle glycogen synthase in type 2 diabetes is associated with diminished phosphatidylinositol 3-kinase activation. J Clin Endocrinol Metab. 2001 Sep; 86(9):4307-14. Nikoulina SE, Ciaraldi TP, Carter L, Mudaliar S, Park KS, Henry RR. PMID: 11549666.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    118. Retinoid X receptor expression in skeletal muscle of nondiabetic, obese and type 2 diabetic individuals. Metabolism. 2001 Jul; 50(7):830-4. Codner E, Loviscach M, Ciaraldi TP, Rehman N, Carter L, Mudaliar S, Henry RR. PMID: 11436190.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    119. Peroxisome proliferator-activated receptor (PPAR) gamma and retinoid X receptor (RXR) agonists have complementary effects on glucose and lipid metabolism in human skeletal muscle. Diabetologia. 2001 Apr; 44(4):444-52. Cha BS, Ciaraldi TP, Carter L, Nikoulina SE, Mudaliar S, Mukherjee R, Paterniti JR, Henry RR. PMID: 11357475.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansCells
    120. Pharmacodynamic and pharmacokinetic properties of a premixed 85/15 human insulin preparation. Clin Ther. 2001 Mar; 23(3):404-12. Mudaliar SR, Mohideen P, Baxi SC, Joyce M, Armstrong DA, Strange P, Henry RR. PMID: 11318075.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCTClinical Trials
    121. Effect of acute exercise on citrate synthase activity in untrained and trained human skeletal muscle. Am J Physiol Regul Integr Comp Physiol. 2001 Feb; 280(2):R441-7. Leek BT, Mudaliar SR, Henry R, Mathieu-Costello O, Richardson RS. PMID: 11208573.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCells
    122. New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers. Annu Rev Med. 2001; 52:239-57. Mudaliar S, Henry RR. PMID: 11160777.
      View in: PubMed   Mentions: 38     Fields:    Translation:Humans
    123. Induction of insulin resistance in human skeletal muscle cells by downregulation of glycogen synthase protein expression. Metabolism. 2000 Aug; 49(8):962-8. Park KS, Ciaraldi TP, Carter L, Mudaliar S, Nikoulina SE, Webster NJ, Henry RR. PMID: 10954011.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    124. Exercise adaptation attenuates VEGF gene expression in human skeletal muscle. Am J Physiol Heart Circ Physiol. 2000 Aug; 279(2):H772-8. Richardson RS, Wagner H, Mudaliar SR, Saucedo E, Henry R, Wagner PD. PMID: 10924077.
      View in: PubMed   Mentions: 55     Fields:    Translation:Humans
    125. Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: relation to insulin action. Diabetologia. 2000 Mar; 43(3):304-11. Loviscach M, Rehman N, Carter L, Mudaliar S, Mohadeen P, Ciaraldi TP, Veerkamp JH, Henry RR. PMID: 10768091.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    126. Potential role of glycogen synthase kinase-3 in skeletal muscle insulin resistance of type 2 diabetes. Diabetes. 2000 Feb; 49(2):263-71. Nikoulina SE, Ciaraldi TP, Mudaliar S, Mohideen P, Carter L, Henry RR. PMID: 10868943.
      View in: PubMed   Mentions: 115     Fields:    Translation:HumansCells
    127. Human VEGF gene expression in skeletal muscle: effect of acute normoxic and hypoxic exercise. Am J Physiol. 1999 12; 277(6):H2247-52. Richardson RS, Wagner H, Mudaliar SR, Henry R, Noyszewski EA, Wagner PD. PMID: 10600843.
      View in: PubMed   Mentions: 45     Fields:    Translation:HumansCells
    128. Glucosamine regulation of glucose metabolism in cultured human skeletal muscle cells: divergent effects on glucose transport/phosphorylation and glycogen synthase in non-diabetic and type 2 diabetic subjects. Endocrinology. 1999 Sep; 140(9):3971-80. Ciaraldi TP, Carter L, Nikoulina S, Mudaliar S, McClain DA, Henry RR. PMID: 10465266.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansCells
    129. Insulin aspart (B28 asp-insulin): a fast-acting analog of human insulin: absorption kinetics and action profile compared with regular human insulin in healthy nondiabetic subjects. Diabetes Care. 1999 Sep; 22(9):1501-6. Mudaliar SR, Lindberg FA, Joyce M, Beerdsen P, Strange P, Lin A, Henry RR. PMID: 10480516.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansCellsCTClinical Trials
    130. Combination therapy for type 2 diabetes. Endocr Pract. 1999 Jul-Aug; 5(4):208-19. Mudaliar S, Henry RR. PMID: 15251678.
      View in: PubMed   Mentions: 2     Fields:    
    131. Inhibition of LDL oxidation in vitro but not ex vivo by troglitazone. Diabetes. 1999 Apr; 48(4):783-90. Crawford RS, Mudaliar SR, Henry RR, Chait A. PMID: 10102695.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    132. Effects of tumor necrosis factor-alpha on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects. Endocrinology. 1998 Dec; 139(12):4793-800. Ciaraldi TP, Carter L, Mudaliar S, Kern PA, Henry RR. PMID: 9832415.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansCells
    133. Troglitazone effects on gene expression in human skeletal muscle of type II diabetes involve up-regulation of peroxisome proliferator-activated receptor-gamma. J Clin Endocrinol Metab. 1998 Aug; 83(8):2830-5. Park KS, Ciaraldi TP, Lindgren K, Abrams-Carter L, Mudaliar S, Nikoulina SE, Tufari SR, Veerkamp JH, Vidal-Puig A, Henry RR. PMID: 9709955.
      View in: PubMed   Mentions: 15     Fields:    Translation:HumansCells
    134. Plasma homocysteine concentrations are regulated by acute hyperinsulinemia in nondiabetic but not type 2 diabetic subjects. Metabolism. 1998 Jun; 47(6):686-9. Fonseca VA, Mudaliar S, Schmidt B, Fink LM, Kern PA, Henry RR. PMID: 9627367.
      View in: PubMed   Mentions: 14     Fields:    Translation:Humans
    135. Lack of effect of leptin on glucose transport, lipoprotein lipase, and insulin action in adipose and muscle cells. Endocrinology. 1998 May; 139(5):2509-13. Ranganathan S, Ciaraldi TP, Henry RR, Mudaliar S, Kern PA. PMID: 9564865.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    136. Troglitazone regulation of glucose metabolism in human skeletal muscle cultures from obese type II diabetic subjects. J Clin Endocrinol Metab. 1998 May; 83(5):1636-43. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR. PMID: 9589670.
      View in: PubMed   Mentions: 14     Fields:    Translation:HumansCells
    137. PPAR-gamma gene expression is elevated in skeletal muscle of obese and type II diabetic subjects. Diabetes. 1997 Jul; 46(7):1230-4. Park KS, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Nikoulina SE, Henry RR. PMID: 9200661.
      View in: PubMed   Mentions: 31     Fields:    Translation:Humans
    138. Regulation of glycogen synthase activity in cultured skeletal muscle cells from subjects with type II diabetes: role of chronic hyperinsulinemia and hyperglycemia. Diabetes. 1997 Jun; 46(6):1017-24. Nikoulina SE, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Henry RR. PMID: 9166674.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    139. Strategies for preventing type II diabetes. What can be done to stem the epidemic? Postgrad Med. 1997 Jan; 101(1):181-6, 189. Mudaliar SR, Henry RR. PMID: 9008696.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    140. Glycogen synthase activity is reduced in cultured skeletal muscle cells of non-insulin-dependent diabetes mellitus subjects. Biochemical and molecular mechanisms. J Clin Invest. 1996 Sep 01; 98(5):1231-6. Henry RR, Ciaraldi TP, Abrams-Carter L, Mudaliar S, Park KS, Nikoulina SE. PMID: 8787686; PMCID: PMC507545.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansCells
    141. Acute and chronic effects of insulin on leptin production in humans: Studies in vivo and in vitro. Diabetes. 1996 May; 45(5):699-701. Kolaczynski JW, Nyce MR, Considine RV, Boden G, Nolan JJ, Henry R, Mudaliar SR, Olefsky J, Caro JF. PMID: 8621027.
      View in: PubMed   Mentions: 89     Fields:    Translation:HumansCells
    142. Role of glycemic control and protein restriction in clinical management of diabetic kidney disease. Endocr Pract. 1996 May-Jun; 2(3):220-6. Mudaliar SR, Henry RR. PMID: 15251545.
      View in: PubMed   Mentions:    Fields:    
    143. Acquired defects of glycogen synthase activity in cultured human skeletal muscle cells: influence of high glucose and insulin levels. Diabetes. 1996 Apr; 45(4):400-7. Henry RR, Ciaraldi TP, Mudaliar S, Abrams L, Nikoulina SE. PMID: 8603759.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    144. Glucose transport in cultured human skeletal muscle cells. Regulation by insulin and glucose in nondiabetic and non-insulin-dependent diabetes mellitus subjects. J Clin Invest. 1995 Dec; 96(6):2820-7. Ciaraldi TP, Abrams L, Nikoulina S, Mudaliar S, Henry RR. PMID: 8675652; PMCID: PMC185992.
      View in: PubMed   Mentions: 42     Fields:    Translation:HumansCells
    Sunder's Networks
    Concepts (485)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (38)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (59)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California